Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Frontiers in gene therapy for erectile dysfunction.

G J Christ1

  • 1Department of Urology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.christ@aecom.yu.edu

International Journal of Impotence Research
|October 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioprinting on sheet-based scaffolds applied to the creation of implantable tissue-engineered constructs with potentially diverse clinical applications: Tissue-Engineered Muscle Repair (TEMR) as a representative testbed.

Connective tissue research·2020
Same author

Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat.

Gene therapy·2008
Same author

Sildenafil: a new oral therapy for erectile dysfunction.

Drugs of today (Barcelona, Spain : 1998)·2003
Same author

K+ channels and gap junctions in the modulation of corporal smooth muscle tone.

Drug news & perspectives·2003
Same author

Gene therapy: future strategies and therapies.

Drugs of today (Barcelona, Spain : 1998)·2003
Same author

The successful long-term treatment of age related erectile dysfunction with hSlo cDNA in rats in vivo.

The Journal of urology·2003

Gene therapy shows promise for treating erectile dysfunction by targeting molecular pathways. Preclinical studies demonstrate proof-of-concept for safe and effective gene transfer, offering a potential new treatment modality.

Area of Science:

  • Genomic medicine
  • Urology
  • Molecular biology

Background:

  • Human genome sequencing enables molecular medicine advancements.
  • Genomic technologies impact erectile dysfunction (ED) understanding, diagnosis, and treatment.
  • Gene therapy is emerging as a potential treatment for smooth muscle diseases, including ED.

Purpose of the Study:

  • To review preclinical evidence for gene therapy in treating erectile dysfunction.
  • To explore molecular targets and strategies for gene-based ED treatment.
  • To assess the potential of gene transfer technology in urology.

Main Methods:

  • Review of preclinical research on gene therapy for ED.
  • Exploration of molecular targets: nitric oxide/guanylate cyclase/cGMP system, growth factors, calcium sensitization, potassium channels.

Related Experiment Videos

  • Investigation of cell-based gene therapy techniques.

    • Main Results:

    • Preclinical success documented for multiple gene-based strategies for ED.
    • Proof-of-concept established for gene therapy in restoring erectile capacity.
    • Identified technical hurdles include delivery vectors, target validation, and efficacy duration.

    Conclusions:

    • Gene therapy offers a potential safe and effective treatment for erectile dysfunction.
    • The multifactorial nature of ED and available regulatory mechanisms support gene-based approaches.
    • Gene transfer technology holds groundbreaking potential for on-demand intracavernous pressure alteration without systemic side effects.